2.53500 EUR
0.005
0.20%
Last update Dec 15, 7:31 PM CET
Main market
Day range
2.5
2.54500
Previous close
2.53000
Open
2.54500
Access this stock data via API
Subscribe
BioInvent International AB
2.54
0.01
0.20%

Financials

Income statement

Fundamentals currency is SEK
Fiscal date 2024 2023 2022 2021
Total reported revenue 4.1M 71.5M 326.1M 19.4M
Cost of revenue
Gross profit
Operating expense
Research & development 42.1M 390.4M 325.9M 258.3M
Selling general and admin 5.4M 51.6M 50.8M 39.4M
Other operating expenses -26.7K
Operating income -43.3M -370.6M -50.5M -278.2M
Non operating interest income
Income 3.9M 40.6M 9.1M 264K
Expense 51.0K 638K 650K 517K
Other income expense
Pretax income -39.5M -330.1M -42.5M -278.4M
Tax provision 12.4K 204K 0 0
Net income -39.5M -330.3M -42.5M -278.4M
Basic EPS -6.5 -5.0 -0.7 -5.1
Diluted EPS -6.5 -5.0 -0.7 -5.1
Basic average shares 6.0M 726.4M 688.5M 606.1M
Diluted average shares 6.0M 726.4M 688.5M 606.1M
EBITDA -38.4M -312.7M -27.1M -263.3M
Net income from continuing op. -43.3M -369.9M -50.9M -278.4M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 39 minutes

12:20
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).